DataLabs Announces Industry's First Middleware Product Built Specifically for the Biopharmaceutical Industry
New integration platform leverages a library of predefined connectors and allows clients to write their own custom connectors, easing the pain of creating and managing system integrations.
IRVINE, Calif.-June 14, 2006-DataLabs, an innovative developer of Internet-based software applications for clinical development, today announced the release of DataLabs Connect™ v2.0. DataLabs Connect is an enterprise-level middleware product built specifically for the biopharmaceutical industry. A first for the industry, DataLabs Connect includes an application server, management portal, connector framework and predefined connectors that integrate the entire suite of DataLabs' products including Galt Associates dsNavigator encoding and dictionary management product and other best-of-breed products.
DataLabs will be at booth #1829 at the DIA Annual Conference
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Full Phase IIIb BATURA Trial Results Show Airsupra Cuts Severe Exacerbations by 47% in Mild Asthma
May 20th 2025Results from the pivotal BATURA trial show that Airsupra (albuterol/budesonide) significantly outperformed albuterol monotherapy in reducing severe asthma exacerbations and systemic corticosteroid exposure, reinforcing its role as a next-generation, anti-inflammatory rescue therapy for mild asthma patients.
